Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Sanchez-Covarrubias L, Slosky LM, Thompson BJ, Davis TP, Ronaldson PT.

Curr Pharm Des. 2014;20(10):1422-49. Review.

2.

Targeting transporters for CNS drug delivery.

Ronaldson PT.

Curr Pharm Des. 2014;20(10):1419-21. No abstract available.

PMID:
23789947
3.

Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.

Chaves C, Shawahna R, Jacob A, Scherrmann JM, Declèves X.

Curr Pharm Des. 2014;20(10):1450-62. Review.

PMID:
23789951
4.

Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.

Pardridge WM.

Expert Opin Ther Targets. 2015;19(8):1059-72. doi: 10.1517/14728222.2015.1042364. Epub 2015 May 2. Review.

PMID:
25936389
5.

Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.

Stenehjem DD, Hartz AM, Bauer B, Anderson GW.

Future Med Chem. 2009 Dec;1(9):1623-41. doi: 10.4155/fmc.09.137. Review.

PMID:
21425983
7.

Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.

Goyal K, Koul V, Singh Y, Anand A.

Cent Nerv Syst Agents Med Chem. 2014;14(1):43-59. Review.

PMID:
25360772
8.

Combinatorial approaches for the identification of brain drug delivery targets.

Stutz CC, Zhang X, Shusta EV.

Curr Pharm Des. 2014;20(10):1564-76. Review.

PMID:
23789958
9.

Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.

Nagpal K, Singh SK, Mishra DN.

Expert Opin Drug Deliv. 2013 Jul;10(7):927-55. doi: 10.1517/17425247.2013.762354. Epub 2013 Jan 21. Review.

PMID:
23330786
10.
11.

Targeting CNS transporters for treatment of neurodegenerative diseases.

Jedlitschky G, Grube M, Mosyagin I, Kroemer HK, Vogelgesang S.

Curr Pharm Des. 2014;20(10):1523-33.

PMID:
23789959
12.

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.

Löscher W, Potschka H.

Prog Neurobiol. 2005 May;76(1):22-76. Review.

PMID:
16011870
13.

The blood-brain barrier choline transporter.

Geldenhuys WJ, Allen DD.

Cent Nerv Syst Agents Med Chem. 2012 Jun;12(2):95-9. Review.

PMID:
22483271
14.

[Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].

Tachikawa M, Uchida Y, Terasaki T.

Brain Nerve. 2013 Feb;65(2):121-36. Review. Japanese.

PMID:
23399670
15.

Drug efflux transporters in the CNS.

Sun H, Dai H, Shaik N, Elmquist WF.

Adv Drug Deliv Rev. 2003 Jan 21;55(1):83-105. Review.

PMID:
12535575
16.

CNS drug delivery systems: novel approaches.

Pathan SA, Iqbal Z, Zaidi SM, Talegaonkar S, Vohra D, Jain GK, Azeem A, Jain N, Lalani JR, Khar RK, Ahmad FJ.

Recent Pat Drug Deliv Formul. 2009 Jan;3(1):71-89. Review.

PMID:
19149731
17.

Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury.

Ronaldson PT, Davis TP.

Brain Res. 2015 Oct 14;1623:39-52. doi: 10.1016/j.brainres.2015.03.018. Epub 2015 Mar 18. Review.

18.

The concept of fraction of drug transported (ft ) with special emphasis on BBB efflux of CNS and antiretroviral drugs.

Prasad B, Unadkat JD.

Clin Pharmacol Ther. 2015 Apr;97(4):320-3. doi: 10.1002/cpt.72. Epub 2015 Feb 13.

PMID:
25669655
19.

Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.

Pardridge WM.

Curr Opin Drug Discov Devel. 2003 Sep;6(5):683-91. Review.

PMID:
14579518
20.

Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Ronaldson PT, Davis TP.

Ther Deliv. 2011 Aug;2(8):1015-41. doi: 10.4155/tde.11.67. Review.

Supplemental Content

Support Center